Phenotype description in KIF5C gene hot-spot mutations responsible for malformations of cortical development (MCD).


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 20 09 2019
revised: 07 06 2020
accepted: 13 06 2020
pubmed: 21 6 2020
medline: 30 3 2021
entrez: 21 6 2020
Statut: ppublish

Résumé

Malformations of cortical development (MCD) represent a large group of brain cortical anomalies characterized by distinctive MRI findings. This 'radiologically-based' classification required re evaluation over time on identified underlying mechanisms (cytogenetic and/or molecular). The understanding of genotype findings (nature of cytogenetic/molecular mutation, cellular pathways consequences, timing, …) draw line of evidence on these distinctive group of conditions whereas sometimes precise and constant recurrent genotype/phenotype correlation may not be present. The clinical diagnosis of MCD is often difficult due to variability and rarity of individual types of malformations. Recent studies have established a relationship between lissencephaly and pathogenic variants in genes involved in the kinesin/tubulin pathways, as the KIF5C gene. Pathogenic variants in the KIF5C gene are a more recently discovered cause of severe developmental delay with epilepsy, characterized by specific malformation of cortical development such as pachygyria. Only seven children have been described to date. We report the natural history of a sixteen years old patient identified carrier of a KIF5C gene mutation who developed infantile epilepsy. We then gather phenotype description and molecular results of all reported patients so far in order to better define this entity.

Identifiants

pubmed: 32562872
pii: S1769-7212(19)30656-1
doi: 10.1016/j.ejmg.2020.103991
pii:
doi:

Substances chimiques

KIF5C protein, human EC 3.6.1.-
Kinesins EC 3.6.4.4

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103991

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Sophie Duquesne (S)

Center for Human Genetics, Cliniques Universitaires Saint Luc, UCLouvain, Brussels, Belgium.

Marie-Cécile Nassogne (MC)

Pediatric Neurology, Cliniques Universitaires Saint Luc, UCLouvain, Brussels, Belgium.

Philippe Clapuyt (P)

Pediatric Radiology, Cliniques Universitaires Saint Luc, UCLouvain, Brussels, Belgium.

Katrien Stouffs (K)

Centre for Medical Genetic, University Hospital of Brussels UZ Brussel, Brussels, Belgium.

Yves Sznajer (Y)

Center for Human Genetics, Cliniques Universitaires Saint Luc, UCLouvain, Brussels, Belgium. Electronic address: yves.sznajer@uclouvain.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH